BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2414648)

  • 1. Preneoplasia and neoplasia of the bronchus, esophagus, and colon: the use of markers in determining phenotypes and classification.
    Trump BF; McDowell EM; Shamsuddin AK; Phelps PC; Purnell DM; Wilson TS; Banks-Schlegel SP; Kurland CL; Harris CC
    Monogr Pathol; 1985; (26):101-39. PubMed ID: 2414648
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunocytochemical evaluation of human esophageal neoplasms and preneoplastic lesions for beta-chorionic gonadotropin, placental lactogen, alpha-fetoprotein, carcinoembryonic antigen, and nonspecific cross-reacting antigen.
    Burg-Kurland CL; Purnell DM; Combs JW; Hillman EA; Harris CC; Trump BF
    Cancer Res; 1986 Jun; 46(6):2936-43. PubMed ID: 2421889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The production of markers by bronchogenic carcinoma: a review.
    Primack A
    Semin Oncol; 1974 Sep; 1(3):235-44. PubMed ID: 4143486
    [No Abstract]   [Full Text] [Related]  

  • 4. Ectopic production of the isolated alpha subunit of the glycoprotein hormones. A quantitative marker in certain cases of cancer.
    Rosen SW; Weintraub BD
    N Engl J Med; 1974 Jun; 290(26):1441-7. PubMed ID: 4831760
    [No Abstract]   [Full Text] [Related]  

  • 5. [Bronchogenic carcinoma and ectopic hormones].
    Wang MQ
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1984 Jun; 7(3):178-81. PubMed ID: 6151487
    [No Abstract]   [Full Text] [Related]  

  • 6. [Serum markers in malignant diseases].
    Peter HH
    Med Lab (Stuttg); 1981 Nov; 34(11):262-71. PubMed ID: 6176842
    [No Abstract]   [Full Text] [Related]  

  • 7. Tumor markers: value and limitations in the management of cancer patients.
    Bates SE; Longo DL
    Cancer Treat Rev; 1985 Sep; 12(3):163-207. PubMed ID: 2416441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone production by bronchogenic carcinoma: a review.
    Broder LE
    Pathobiol Annu; 1979; 9():205-24. PubMed ID: 225709
    [No Abstract]   [Full Text] [Related]  

  • 9. [Fetal and placental proteins in ovarian cancer].
    Tatra G; Ludwig H
    Gynakol Rundsch; 1980 Jun; 20 Suppl 2():138-41. PubMed ID: 6163685
    [No Abstract]   [Full Text] [Related]  

  • 10. Editorial: When is a tumor marker not a tumor marker?
    Vaitukaitis JL
    N Engl J Med; 1975 Dec; 293(26):1370-1. PubMed ID: 52844
    [No Abstract]   [Full Text] [Related]  

  • 11. Biological markers in lung cancer: an immunocytochemical approach.
    Heyderman E; Chapman DV; Richardson TC
    Cancer Detect Prev; 1982; 5(4):427-49. PubMed ID: 6189609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Placental and embryonal proteins as antigens in the immunodiagnosis of malignant tumors].
    Tatarinov IuS
    Vestn Akad Med Nauk SSSR; 1977; (10):90-3. PubMed ID: 72463
    [No Abstract]   [Full Text] [Related]  

  • 13. Oncofetal and oncoplacental antigens as tumor markers.
    Yamauchi S; Miyake H
    Kitasato Arch Exp Med; 1988 Sep; 61(2-3):95-109. PubMed ID: 2463397
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunocytochemical evaluation of primary human esophageal carcinomas and their xenografts for keratin, beta-chorionic gonadotropin, placental lactogen, alpha-fetoprotein, carcinoembryonic antigen, and nonspecific cross-reacting antigen.
    Burg-Kurland CL; Purnell DM; Combs JW; Valerio MG; Harris CC; Trump BF
    Cancer Res; 1986 Nov; 46(11):5730-7. PubMed ID: 2428482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical biochemistry with radioimmunoassay (author's transl)].
    Irie M
    Seikagaku; 1979 Jul; 51(7):505-25. PubMed ID: 536642
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of tumour markers in malignant mesothelioma and pulmonary adenocarcinoma.
    Gibbs AR; Harach R; Wagner JC; Jasani B
    Thorax; 1985 Feb; 40(2):91-5. PubMed ID: 2579450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Significance of the contemporary determination of tumor associated antigens in patients with various types of neoplasms of the genital tract].
    Sacco F; Benedetti Panici P; Villani L; Di Roberto P; Barile G; Iacobelli S
    Minerva Ginecol; 1978 Oct; 30(10):811-6. PubMed ID: 82920
    [No Abstract]   [Full Text] [Related]  

  • 18. Biological markers in gynecologic cancers. An overview.
    Dini MM; Miller M
    IMJ Ill Med J; 1984 Sep; 166(3):166-71. PubMed ID: 6208177
    [No Abstract]   [Full Text] [Related]  

  • 19. [Serum and urinary markers in pulmonary microcytoma].
    Tomassone W; Cappello F; Lanfranco G; Aroasio E; Bellini A; Porta L
    Boll Soc Ital Biol Sper; 1982 Apr; 58(7):432-6. PubMed ID: 6123333
    [No Abstract]   [Full Text] [Related]  

  • 20. Tumor-associated antigens in polyps and carcinoma of the human large bowel.
    Skinner JM; Whitehead R
    Cancer; 1981 Mar; 47(6):1241-5. PubMed ID: 6164469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.